Obesity Therapy
Roux-en-Y gastric bypass risk compared between super-super-obese and morbidly obese
Published in Obesity and Diabetes Week, March 20th, 2006
"Roux-en-Y gastric bypass (RYGBP) reduces the comorbidities of obesity. Patients with super-super obesity (BMI {{>=}}60) present additional technical and medical challenges. This study compares the results in super-super-obese patients with patients with a BMI of <60 over a 5.5-year period," researchers in the United States report.
J.D. Taylor and colleagues working with the Beth Israel Medical Center explained, "Retrospective analysis was performed of the 504 patients who underwent open RYGBP from January 1999 through June 2004. Patients were divided into...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Complementary & Alternative Medicine
Chromium supplement enhances cellular insulin signaling in obese insulin-resistant rats - Geriatrics
Weight loss improves the health of elderly with type 2 diabetes mellitus - Insulin Resistance
Adiponectin linked to insulin sensitivity independent of visceral adipose tissue - Obesity Epidemiology
Leptin receptor gene polymorphisms linked to obesity and type 2 diabetes mellitus - Obesity Therapy
Weight loss produced by orlistat reduced the incidence of diabetes - Adverse Drug Reaction
Valproate lowers glucose and raises insulin, cortisol, leptin, and neuropeptide Y levels - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
